Evidence map›Paper›PMID 33628101›Full record

ArticleInternational journal of medical sciences2021

ATF4 promotes lung cancer cell proliferation and invasion partially through regulating Wnt/β-catenin signaling.

Jiang Du, Haifeng Liu, Xiaoyun Mao, Yanan Qin, Chuifeng Fan

Open access · goldAbstract read
In one paragraph

Article in International journal of medical sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. CBP/β-Catenin Signaling in Hepatocytes Plays Pivotal Roles in MMP-7-Mediated Liver Fibrosis in a Metabolic Dysfunction-Associated Steatohepatitis Mouse Model.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  4. Article
  5. Article
  6. Targeting the Glutaminolysis Pathway in Glaucoma-Associated Fibrosis.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Anticancer activities of natural abietic acid.Frontiers in pharmacology · 2024
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jiang DuDepartment of Pathology, First affiliated hospital and College of Basic Medical Sciences of China Medical University, 110001, Shenyang, China.
Haifeng LiuDepartment of Pathology, First affiliated hospital and College of Basic Medical Sciences of China Medical University, 110001, Shenyang, China.
Xiaoyun MaoDepartment of Breast Surgery, Department of Surgical Oncology, Research Unit of General Surgery, the First Affiliated Hospital of China Medical University, 110001, Shenyang, China.
Yanan QinDepartment of Pathology, First affiliated hospital and College of Basic Medical Sciences of China Medical University, 110001, Shenyang, China.
Chuifeng FanDepartment of Pathology, First affiliated hospital and College of Basic Medical Sciences of China Medical University, 110001, Shenyang, China.
First Hospital of China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Activating transcription factor 4 (ATF4) is a member of the cAMP response element binding (CREB) protein family and has been reported to participate in cancer progression; however, its molecular mechanism is not fully understood. In this study, we investigated the function of ATF4 in non-small cell lung cancer and its molecular regulation. We detected cytoplasmic and nuclear ATF4 expression in lung cancer A549, H1299, and LK2 cells, and the total expression of ATF4 was higher than that in HBE cells (

Indexed as

Wnt Signaling PathwayActivating Transcription Factor 4beta CateninBridged Bicyclo Compounds, HeterocyclicCell Line, TumorCell MovementCell ProliferationHumansLung NeoplasmsNeoplasm InvasivenessPyrimidinonesActivating Transcription Factor 4ATF4 protein, humanbeta CateninBridged Bicyclo Compounds, HeterocyclicCTNNB1 protein, humanICG 001PyrimidinonesATF4invasionlung cancerproliferationβ-catenin

Identifiers

PMID33628101
PMCPMC7893563
OpenAlexW3130886774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.